Drug intelligence / Profile preview

vitten

Development stage
Unknown
Lead developer
JETEMA
Administration
Intradermal
01

Overview

Vitten is a line of injectable mesotherapy solutions developed by JETEMA Co., Ltd. for aesthetic and dermatological applications. The primary active ingredient in the Vitten collection is hyaluronic acid, which is utilized to provide deep dermal hydration and stimulate collagen production. The product line includes Vitten Hydro, containing non-cross-linked hyaluronic acid (15 mg/mL), and Vitten Hydro Plus, containing semi-cross-linked hyaluronic acid (15 mg/mL). These solutions are administered via intradermal injection to deliver hydration and nutrients directly to the skin, targeting concerns such as wrinkles, fine lines, dryness, and loss of elasticity. Additionally, the line includes Vitten Hair Rx, a formulation specifically designed for hair restoration. The biological mechanism focuses on restoring the skin barrier and providing significant moisture retention (reportedly 200-300 times normal levels).

Brand names
vittenVitten HydroVitten Hydro PlusVitten Hair Rx
Other names
vitten Meso Solution

Beyond the preview

Go deeper on vitten.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on vitten.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call